GTC Biotherapeutics (fka GTCB)

[shears]

The question I have about the LFB deal is whether the future value of the shares sold is roughly equal to the cash gained and future revenues minus expenses? They could have diluted by other means to raise cash or raised cash with development deals. Where will GTCB's market cap be in 2013? Between now and then how many other protein production/royalty deals will be in place and producing revenue? Is 50% of what LFB has to offer that valuable? GTCB must think so. I think they blew their wad in terms of dilution with this deal. I hope they know what they're doing and what the true potential of this deal is beyond factor VII. It better be big because as I see it they gave up alot for a measely $25M. I'll hold what I have but I'm tired of being diluted and I am less likely to add to what I have till I see some more deals and revenue streams come to fruition.